Drug safety profile of integrase strand transfer inhibitors

Author： del Mar Gutierrez Maria Mateo Maria Gracia Vidal Francesc Domingo Pere

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.4, 2014-04, pp. : 431-445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor

Current Clinical Pharmacology, Vol. 11, Iss. 2, 2016-08 ,pp. : 88-94

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Studies of N-substituted Quinolinonyl Diketo Acid Derivatives as HIV Integrase Strand Transfer Inhibitors using 3D-QSAR, Pharmacophore Modeling and Molecular Docking

Letters in Drug Design & Discovery, Vol. 14, Iss. 11, 2017-10 ,pp. : 1291-1302

Bentham Science Publishers

Access to resources Recommend Favorite

Insight into integrase inhibitors

Inpharma, Vol. 1, Iss. 1608, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Novel integrase inhibitors for HIV

By Prada Nicole Markowitz Martin

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 9, 2010-09 ,pp. : 1087-1098

Informa Healthcare

Access to resources Recommend Favorite

HIV integrase inhibitors

By Sotriffer Christoph

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 284-290

Govi-Verlag

Access to resources Recommend Favorite